Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21), a glucose and lipid metabolic regulator, has recently been demonstrated to be associated with cardiovascular diseases (CVD) such as carotid atherosclerosis, coronary heart disease and carotid artery plaques. However, the relationship between circulati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Diabetol
Principais autores: Xiao, Yang, Liu, Lingjiao, Xu, Aimin, Zhou, Pengcheng, Long, Zhaofeng, Tu, Yiting, Chen, Xiaoyan, Tang, Weili, Huang, Gan, Zhou, Zhiguang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475300/
https://ncbi.nlm.nih.gov/pubmed/26047614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0229-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados